Cwm LLC Buys 766 Shares of Perrigo Company plc (NYSE:PRGO)

Cwm LLC increased its stake in Perrigo Company plc (NYSE:PRGO – Get Rating) by 315.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,009 shares of the company’s stock after purchasing an additional 766 shares during the quarter. Cwm LLC’s holdings in Perrigo were worth $36,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of PRGO. Point72 Asset Management L.P. bought a new position in Perrigo in the 2nd quarter worth $59,147,000. Pictet Asset Management SA raised its holdings in Perrigo by 11,414.0% in the 2nd quarter. Pictet Asset Management SA now owns 996,535 shares of the company’s stock worth $40,429,000 after purchasing an additional 987,880 shares during the period. Victory Capital Management Inc. increased its stake in Perrigo by 227.6% in the 2nd quarter. Victory Capital Management Inc. now owns 1,039,519 shares of the company’s stock worth $42,174,000 after buying an additional 722,250 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in Perrigo in the 1st quarter worth $24,684,000. Finally, BlackRock Inc. increased its stake in Perrigo by 4.8% in the 1st quarter. BlackRock Inc. now owns 12,112,154 shares of the company’s stock worth $465,469,000 after buying an additional 554,915 shares in the last quarter. 94.09% of the stock is owned by institutional investors.

Perrigo Stock Performance

Shares of Perrigo stock opened at $36.52 on Friday. The firm has a market cap of $4.92 billion, a price-to-earnings ratio of -57.97 and a beta of 0.79. The business has a 50-day moving average price of $33.44 and a 200-day moving average price of $37.45. The company has a quick ratio of 1.48, a current ratio of 2.55 and a debt-to-equity ratio of 0.89. Perrigo Company plc has a twelve month low of $30.78 and a twelve month high of $43.90.

Perrigo (NYSE:PRGO – Get Rating) last released its quarterly earnings results on Tuesday, November 8th. The company reported $0.56 EPS for the quarter, missing the consensus estimate of $0.66 by ($0.10). The company had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.14 billion. Perrigo had a positive return on equity of 5.31% and a negative net margin of 1.93%. The company’s revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.45 EPS. Equities research analysts anticipate that Perrigo Company plc will post 2.02 EPS for the current fiscal year.

Perrigo Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 20th. Investors of record on Friday, December 2nd were given a $0.26 dividend. The ex-dividend date was Thursday, December 1st. This represents a $1.04 annualized dividend and a yield of 2.85%. Perrigo’s dividend payout ratio is currently -165.08%.

Analysts Set New Price Targets

PRGO has been the subject of a number of analyst reports. Raymond James cut their price target on Perrigo from $48.00 to $42.00 and set an “outperform” rating for the company in a research note on Wednesday, November 9th. StockNews.com initiated coverage on Perrigo in a research note on Wednesday, October 12th. They issued a “hold” rating for the company.

Insider Buying and Selling

In other Perrigo news, EVP Grainne Quinn sold 2,368 shares of the firm’s stock in a transaction dated Friday, December 16th. The shares were sold at an average price of $31.65, for a total value of $74,947.20. Following the completion of the sale, the executive vice president now owns 9,118 shares of the company’s stock, valued at $288,584.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.80% of the stock is currently owned by company insiders.

About Perrigo

(Get Rating)

Perrigo Co Plc engages in the provision of self-care products and over-the-counter (OTC) health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. It operates through the following segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI).